Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • 1
    News

    Patients presenting with saddle pulmonary emboli (PE) versus nonsaddle PE have no mortality difference but have an increased risk for decompensation

    April 11, 2018

    Do saddle pulmonary embolisms have worse outcomes compared to nonsaddle pulmonary embolisms?

  • 1
    News

    Using data to drive quality improvement projects

    April 11, 2018

    Attendees will learn how to develop balanced metrics for quality improvement projects, understand distinctions between quality improvement and traditional research projects, and identify how different measures of the same data can tell vastly different stories.

  • News

    Neuro updates: Longer stroke window; hold the fresh frozen plasma

    April 10, 2018

    For ischemic stroke, very good evidence for mechanical thrombectomy, with new data pointing to a prolonged treatment window for some patients.

  • 1
    News

    Two scoring systems helpful in diagnosing heparin-induced thrombocytopenia

    April 8, 2018

    SAN DIEGO – Both the 4Ts Score or the HIT Expert Probability (HEP) Score performed well in a real-world study.

  • 1
    News

    Few acutely ill hospitalized patients receive VTE prophylaxis

    April 2, 2018

    The results “imply that there is a significantly unmet need for effective VTE prophylaxis in both the inpatient and outpatient continuum of care.”

  • 1
    News

    Protocol helped identify hospitalized children at risk for VTE

    March 30, 2018

    SAN DIEGO – Children with hospital-acquired VTE tended to be more medically complex, a single-center study showed.

  • 1
    News

    Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly

    March 30, 2018

    SAN DIEGO – Limiting the initial dose of warfarin to 2.5 mg or less for hospitalized patients aged 85 years and older led to significant reductions in supratherapeutic INRs.

  • 1
    Article

    Many VTE patients live in fear of the next event

    March 29, 2018

    An estimated 41% of patients who experience a VTE fear another clot often or almost all the time.

  • 1
    Video

    VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant 

    March 21, 2018

    ORLANDO – Now that reversal is possible prescriptions for the already-popular direct Factor Xa inhibitor, anticoagulants should spike higher.

  • 1
    News

    Beware of polypharmacy in patients taking warfarin

    March 20, 2018

    SAN DIEGO – The incidence of polypharmacy among patients on warfarin therapy appears to peak at age 75.

Previous1 … 16 17 18 19 20 … 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences